Heike Wulff
12Patents
1h-index
27Co-inventors
54Inventor score
Filing activity: Jan 6, 2000 → Nov 16, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6803375B1 | Non-peptide inhibition of T-lymphocyte activation and therapies related thereto | Human Necessities | 1 | Expired |
| US7235577B1 | Non-peptide inhibition of T-lymphocyte activation and therapies related thereto | Human Necessities | 0 | Expired |
| US11974988B2 | Neuroprotective compositions and methods of using the same | Chemistry; Metallurgy | 0 | Active |
| US8063093B2 | Potassium channel blockers and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US6541494B1 | Non-peptide inhibition of T-lymphocyte activation and therapies related thereto | General | 0 | Revoked |
| US8026263B2 | Methods for inhibiting neoproliferative changes in blood vessel walls | Human Necessities | 0 | Expired |
| US7557138B2 | 5-phenoxyalkoxypsoralens and methods for selective inhibition of the voltage gated Kv1.3 potassium channel | Human Necessities | 0 | Expired |
| US9675591B2 | Methods for treating seizure disorders and pain | Chemistry; Metallurgy | 0 | Active |
| US8067460B2 | 5-phenoxyalkoxypsoralens and methods for selective inhibition of the voltage gated Kv1.3 potassium channel | Human Necessities | 0 | Active |
| US7507839B2 | Therapeutic ion channel blocking agents and methods of use thereof | Chemistry; Metallurgy | 0 | Expired |
| US11173146B2 | Selective activators of the intermediate conductance CA2+activated K+ channel KCa3.1 and their methods of use | Human Necessities | 0 | Active |
| US7772408B1 | Substituted 5-alkoxypsoralens as inhibitors of potassium channel activity in lymphocytes and other cells | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.